FGFu-Sheng Gao

Fu-Sheng Gao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Fu-Sheng Gao has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Ge Song

    Affiliated Hospital of Weifang Medical University, Weifang Medical University

    1 shared publication
  • Hui-Min Sun

    Affiliated Hospital of Weifang Medical University, Weifang Medical University

    1 shared publication
  • Jun Man

    Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Shandong Second Medical University, Weifang City, China

    1 shared publication
  • Ling-Xuan Zhang

    Affiliated Hospital of Weifang Medical University, Weifang Medical University

    1 shared publication
  • Longfei Song

    Department of Rehabilitation Medicine, Affiliated Hospital of Shandong Second Medical University, Weifang City, China

    1 shared publication
  • Mei-Juan Liu

    Department of Respiratory Medicine, The Affiliated Hospital of Weifang Medical College, Weifang, China

    1 shared publication

Latest Publications

  • Open Access

    LncRNA FEZF1-AS1 promotes pulmonary fibrosis via up-regulating EZH2 and targeting miR-200c-3p to regulate the ZEB1 pathway

    by Mengmeng Liu, Longfei Song, Yuxin Lai, Fusheng Gao, Jun Man

    The role and detailed mechanisms of lncRNAs in idiopathic pulmonary fibrosis (IPF) are not fully understood. qPCR was conducted to verify lncRNA FEZF1-AS1 expression in the transforming growth factor-beta 1 (TGF-β1)-stimulated human lung fibroblasts (HLF) and A549. The EMT-related proteins were performed by western blotting. Cell proliferation, migration, and transition were detected by CCK-8, colony formation, wound-healing and transwell assays. A dual-luciferase reporter assay was conducted to validate the target relationship of FEZF1-AS1 and miR-200c-3p. FEZF1-AS1 is highly expressed in the fibrotic A549 and HLF. in vitro experiments revealed that FEZF1-AS1 facilitates cell proliferation, migration and invasion. Knockdown of FEZF1-AS1 attenuated TGF-b1-induced fibrogenesis both in vitro. Moreover, silencing FEZF1-AS1 inhibited fibrogenesis through modulation of miR-200c-3p. In addition, inhibition of miR-200c-3p promoted fibrogenesis by regulation of Zinc finger E-box binding homeobox 1 (ZEB1). Mechanistically, FEZF1-AS1 promoted lung fibrosis by acting as a competing endogenous RNA (ceRNA) for miR-200c-3p. FEZF1-AS1 silencing increased the expression and activity of miR-200c-3p to inhibit ZEB1 and alleviate lung fibrogenesis in A549 and HLF. In addition, our study showed that FEZF1-AS1 can regulate enhancer of zeste homolog2 (EZH2) to upregulate fibrosis-related proteins and promote lung fibrosis. In summary, the results of our study revealed the pulmonary fibrogenic effect of FEZF1-AS1 in cellular experiments, demonstrating the potential roles and mechanisms of the FEZF1-AS1/miR-200c-3p/ZEB1 and FEZF1-AS1/EZH2 pathways, which provides a novel and potential therapeutic target to lung fibrosis.


  • Open Access

    Aspergillus fumigatus extracts upregulated mucin 5AC expression in human 16HBE bronchial epithelial cells through activation of the EGFR-MEK-ERK1/2 pathway

    by Ling-Xuan Zhang, Meng Li, Ge Song, Hui-Min Sun, Fu-Sheng Gao

    Background It has been demonstrated that Aspergillus fumigatus exposure leads to upregulation of MUC5AC expression in the airways epithelial cells. However, the signal pathway through which Aspergillus fumigatus induce MUC5AC expression is unknown. In this study the possible signal pathways of Aspergillus fumigatus extract (AFE) to regulate the expression of MUC5AC were investigated in human bronchial epithelial cells. Methods The 16HBE cells were divided into 4 groups: normal medium control group, AFE-treated group, AFE + selective inhibitor of protein tyrosine kinase of EGFR (AG1478) treated group, and AFE + inhibitor of MAPK kinase (MEK) (PD98059) treated group. The expression of EGFR, extracellular-signal regulated kinase 1/2 (ERK1/2), phospho-EGFR, phospho-ERK1/2 and MUC5AC were measured by immunofluorescence, immunohistochemistry, RT-PCR, and Western blot . Results Incubation with 16HBE cells for 24 h, AFE dose-dependently upregulated the expression of EGFR and ERK1/2; Incubation with 16HBE cells for 1 h, 16mg/L of AFE induced phosphorylation of EGFR and ERK1/2; Incubation with 16HBE cells, 10 M/L of AG1478 inhibited the phosphorylation of EGFR and ERK1/2, whereas 30 M/L of PD98059 only inhibited the phosphorylation of ERK1/2 and had no influence on the phosphorylation of EGFR. 16mg/L of AFE upregulated the expression of MUC5AC in 16HBE cells. The expression of MUC5AC induced by AFE in 16HBE cells could be inhibited after incubation with AG1478 or PD98059. Conclusion Activation of EGFR-MEK-ERK1/2 signal pathway is one of the mechanisms by which Aspergillus fumigatus upregulate the expression of MUC5AC in 16HBE cells.

  • ChronicAspergillus fumigatusexposure upregulates the expression of mucin 5AC in the airways of asthmatic rats

    by Fu-Sheng Gao, Yan-Yan Gao, Mei-Juan Liu, Yong-Quan Liu

    Background: Airway mucus hypersecretion is associated with increased morbidity and mortality in patients with asthma. Chronic Aspergillus fumigatus (A. fumigatus) exposure leads to aggravation of airway inflammation and remodeling, including goblet cell hyperplasia (GCH) and mucus hypersecretion in a rat model of asthma. The effects of chronic A. fumigatus exposure on the expression of airway mucin 5AC (MUC5AC) are unknown. Methods: The rat model of chronic asthma was set up by systemic sensitization and repeated challenge to ovalbumin (OVA). The asthmatic rats were exposed to chronic intranasal inhalation of A. fumigatus spores. The changes of MUC5AC expression, the extent of GCH, and airway hyperreactivity (AHR) were measured after exposure to the fungus. Results and Conclusions: Chronic exposure to A. fumigatus upregulates the expression of MUC5AC, and induces GCH in the airways of asthma rats, and the remodeling changes of the airway epithelium was positively correlated with AHR. Upregulation of MUC5AC and induction of GCH may be mechanisms by which chronic A. fumigatus exposure promotes the progression of asthma.